Allergy Therapeutics PLC AGYTF
Trading Information
- Previous Close Price
- $0.14
- Day Range
- $0.15–0.15
- 52-Week Range
- $0.09–0.15
- Bid/Ask
- $0.15 / $208,000.00
- Shares Outstanding
- 6.33B
- Market Cap
- $949.88M
- Volume/Avg
- 7,142 / 24,298
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 9.93
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Allergy Therapeutics plc is an international biotechnology group focused on the diagnosis and treatment of allergic disorders through immunotherapies that target the underlying cause of disease. Its portfolio includes Pollinex, Pollinex Quattro, Acarovac, Tyrosine S/TU, Venomil, Oralvac and other allergy immunotherapy products, supported by R&D programmes such as Grass MATA MPL and VLP Peanut. The Group operates in a single class of business, being the manufacture and sale of allergy-related medicines, and maintains centralised manufacturing and research and development capabilities in the UK. Its geographical presence covers Central Europe (Germany, Austria, Switzerland and the Netherlands), Southern Europe (Spain and Italy) and the Rest of the World (including the UK).
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 576
Valuation
|
Metric
|
AGYTF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 435.13 |
Price/Sales | 9.93 |
Price/Cash Flow | — |
Price/Earnings
AGYTF
Financial Strength
|
Metric
|
AGYTF
|
|---|---|
Quick Ratio | 0.70 |
Current Ratio | 1.13 |
Interest Coverage | −5.49 |
Quick Ratio
AGYTF
Profitability
|
Metric
|
AGYTF
|
|---|---|
Return on Assets (Normalized) | −59.99% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −110.84% |
Return on Assets
AGYTF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|T<LbBc@r | LOCK|&!!L | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|@&@F$QZ | LOCK|$Y^<s | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|v$HC%>K | LOCK|pt@ | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|mCshTJ$d | LOCK|R!K | $33B | |||
| Viatris Inc
VTRS
| LOCK|#ZnlP@? | LOCK|Pnk | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|?$ | LOCK|!k | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|b&XcY>? | LOCK|%H | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|V>b$>^ | LOCK|m@S | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|@WZWG?% | LOCK|k>nY^ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|Q&!#KK | LOCK|?^P | $2B |
United States